IFM Investors Pty Ltd increased its position in Citigroup Inc. (NYSE:C - Free Report) by 8.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 388,346 shares of the company's stock after buying an additional 30,226 shares during the quarter. IFM Investors Pty Ltd's holdings in Citigroup were worth $27,569,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also made changes to their positions in the company. American Century Companies Inc. grew its stake in Citigroup by 3.4% during the fourth quarter. American Century Companies Inc. now owns 352,948 shares of the company's stock worth $24,844,000 after buying an additional 11,674 shares during the period. Invesco Ltd. lifted its holdings in shares of Citigroup by 13.8% during the 4th quarter. Invesco Ltd. now owns 16,247,095 shares of the company's stock valued at $1,143,633,000 after acquiring an additional 1,970,300 shares in the last quarter. Candriam S.C.A. boosted its position in Citigroup by 12.7% during the 4th quarter. Candriam S.C.A. now owns 200,860 shares of the company's stock worth $14,139,000 after purchasing an additional 22,657 shares during the period. Brighton Jones LLC boosted its position in Citigroup by 166.9% during the 4th quarter. Brighton Jones LLC now owns 19,990 shares of the company's stock worth $1,407,000 after purchasing an additional 12,499 shares during the period. Finally, Mackenzie Financial Corp increased its holdings in Citigroup by 30.1% in the 4th quarter. Mackenzie Financial Corp now owns 1,876,682 shares of the company's stock valued at $132,100,000 after purchasing an additional 434,280 shares in the last quarter. 71.72% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, Director John Cunningham Dugan sold 4,417 shares of Citigroup stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $68.26, for a total value of $301,504.42. Following the completion of the transaction, the director owned 13,048 shares in the company, valued at approximately $890,656.48. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.08% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of brokerages have commented on C. Piper Sandler restated an "overweight" rating and set a $77.00 price objective (down previously from $83.00) on shares of Citigroup in a research note on Wednesday, April 16th. Evercore ISI increased their price objective on shares of Citigroup from $76.00 to $77.00 and gave the company an "in-line" rating in a research report on Wednesday. TD Cowen initiated coverage on shares of Citigroup in a research note on Thursday, May 15th. They set a "hold" rating and a $83.00 price objective on the stock. Truist Financial decreased their target price on shares of Citigroup from $84.00 to $79.00 and set a "buy" rating for the company in a research note on Wednesday, April 16th. Finally, The Goldman Sachs Group raised their price target on shares of Citigroup from $85.00 to $96.00 and gave the company a "buy" rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Citigroup currently has an average rating of "Moderate Buy" and a consensus target price of $85.43.
View Our Latest Research Report on C
Citigroup Stock Up 2.2%
Shares of C traded up $1.91 during midday trading on Friday, hitting $88.67. The company had a trading volume of 13,229,886 shares, compared to its average volume of 14,629,018. The stock has a market cap of $165.61 billion, a price-to-earnings ratio of 14.02, a PEG ratio of 0.69 and a beta of 1.34. The company's 50 day moving average price is $76.22 and its 200 day moving average price is $74.04. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.52. Citigroup Inc. has a 52 week low of $53.51 and a 52 week high of $88.80.
Citigroup (NYSE:C - Get Free Report) last posted its quarterly earnings results on Tuesday, April 15th. The company reported $1.96 EPS for the quarter, topping analysts' consensus estimates of $1.84 by $0.12. The business had revenue of $21.60 billion during the quarter, compared to the consensus estimate of $21.34 billion. Citigroup had a return on equity of 6.94% and a net margin of 7.95%. On average, equities research analysts predict that Citigroup Inc. will post 7.53 EPS for the current year.
About Citigroup
(
Free Report)
Citigroup Inc, a diversified financial service holding company, provides various financial product and services to consumers, corporations, governments, and institutions worldwide. It operates through five segments: Services, Markets, Banking, U.S. Personal Banking, and Wealth. The Services segment includes Treasury and Trade Solutions, which provides cash management, trade, and working capital solutions to multinational corporations, financial institutions, and public sector organizations; and Securities Services, such as cross-border support for clients, local market expertise, post-trade technologies, data solutions, and various securities services solutions.
Read More

Before you consider Citigroup, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Citigroup wasn't on the list.
While Citigroup currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.